Chlorozotocin
.svg)
Chlorozotocin is a chemotherapy agent that belongs to the class of nitrosourea compounds. It is primarily used in the treatment of certain types of cancer, particularly pancreatic cancer and colon cancer. Chlorozotocin is known for its ability to cross the blood-brain barrier, making it a potential treatment option for brain tumors.
Chemical Structure and Properties[edit | edit source]
Chlorozotocin is a synthetic compound that combines the properties of nitrosourea and glucose moieties. Its chemical structure allows it to alkylate DNA, leading to the disruption of DNA replication and cell division. This mechanism is crucial for its effectiveness as an antineoplastic agent.
Mechanism of Action[edit | edit source]
The primary mechanism of action of chlorozotocin involves the alkylation of DNA. This process results in the formation of cross-links within the DNA strands, inhibiting DNA synthesis and function. The disruption of DNA ultimately leads to apoptosis or programmed cell death of the cancer cells.
Clinical Uses[edit | edit source]
Chlorozotocin has been investigated for its efficacy in treating various types of cancer. It has shown promise in the treatment of:
Side Effects[edit | edit source]
As with many chemotherapy agents, chlorozotocin is associated with a range of side effects. Common side effects include:
- Myelosuppression, leading to decreased white blood cell count
- Nausea and vomiting
- Nephrotoxicity
- Hepatotoxicity
Administration[edit | edit source]
Chlorozotocin is typically administered intravenously. The dosage and frequency of administration depend on the type and stage of cancer being treated, as well as the patient's overall health and response to the drug.
Research and Development[edit | edit source]
Ongoing research is focused on improving the efficacy and reducing the toxicity of chlorozotocin. Studies are also exploring its potential use in combination with other chemotherapy agents and targeted therapies.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
